Automated Deep Learning Segmentation of Cardiac Inflammatory FDG PET

Background: Fluorodeoxyglucose positron emission tomography (FDG PET) with glycolytic metabolism suppression plays a pivotal role in diagnosing cardiac sarcoidosis. Reorientation of images to match perfusion datasets is critical and myocardial segmentation enables consistent image scaling and quantification. However, both are challenging and labor intensive. We developed a 3D U-Net deep learning (DL) algorithm for automated myocardial segmentation in cardiac sarcoidosis FDG PET. Methods: The DL model was trained on 316 patients' FDG PET scans, and left ventricular contours derived from perfusion datasets. Qualitative analysis of clinical readability was performed to compare DL segmentation with the current automated method on a 50-patient test subset. Additionally, left ventricle displacement and angulation, as well as SUVmax sampling were compared to inter-user reproducibility results. Results: DL segmentation enhanced readability scores in over 90% of cases compared to the standard segmentation currently used in the software. DL segmentation performed similarly to a trained technologist, surpassing standard segmentation for left ventricle displacement and angulation, as well as correlation of SUVmax. Conclusion: The DL-based automated segmentation tool presents a marked improvement in the processing of cardiac sarcoidosis FDG PET, promising enhanced clinical workflow. This tool holds significant potential for accelerating clinical practice and improving consistency and quality. Further research with varied datasets is warranted to broaden its applicability.

[1]  V. Murthy,et al.  Utility of serum ketone levels for assessment of myocardial glucose suppression for ^18F-fluorodeoxyglucose PET in patients referred for evaluation of endocarditis , 2023, Journal of Nuclear Cardiology.

[2]  V. Murthy,et al.  The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis , 2021, Journal of Nuclear Cardiology.

[3]  Xiaowei Ding,et al.  Embracing Imperfect Datasets: A Review of Deep Learning Solutions for Medical Image Segmentation , 2019, Medical Image Anal..

[4]  V. Murthy,et al.  Characterization of a highly effective preparation for suppression of myocardial glucose utilization , 2019, Journal of Nuclear Cardiology.

[5]  Paul J. Kennedy,et al.  Deep Learning Techniques for Medical Image Segmentation: Achievements and Challenges , 2019, Journal of Digital Imaging.

[6]  A. Alavi,et al.  The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis , 2017, Journal of Nuclear Cardiology.

[7]  Thomas Brox,et al.  3D U-Net: Learning Dense Volumetric Segmentation from Sparse Annotation , 2016, MICCAI.

[8]  R. Blankstein,et al.  Cardiac sarcoidosis-state of the art review. , 2016, Cardiovascular diagnosis and therapy.

[9]  B. Iung,et al.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.

[10]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[11]  Jon Hainer,et al.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. , 2012, Journal of the American College of Cardiology.

[12]  Benjamin C. Lee,et al.  Corridor4DM: The Michigan method for quantitative nuclear cardiology , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[13]  H. Fleming,et al.  Cardiac Sarcoidosis , 1986, Clinics in dermatology.